今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

5G商用五年硕果累累 融合创新开辟广阔空间

北京讯（记者 张玉） 今年是5G商用的第五个年头。五年来，我国5G网络建设取得了举世瞩目的成就，为经济社会高质量发展注入了强劲动力。

截至2024年4月底，我国累计建成5G基站374.8万个，每万人拥有5G基站数超26个，5G网络已实现全国所有地市级城区、县城城区覆盖，正加快向农村地区延伸。我国5G用户规模突破5亿，5G终端连接数超过10亿，产业链整体实力不断增强。

5G的商用拓展和融合创新，正在为各行各业带来深刻变革。在工业领域，5G赋能工业互联网，推动生产模式转型升级。例如，在宝钢湛江分公司，5G与人工智能、大数据等技术深度融合，实现了全流程智能制造，生产效率大幅提升。在医疗领域，5G远程医疗、智慧医院等应用不断涌现，为患者提供更加便捷、高效的医疗服务。例如，在北京协和医院，5G远程超声系统实现了专家远程会诊，使偏远地区患者也能享受优质医疗资源。

5G-A赋能实体经济新活力

5G-A是5G技术的演进方向，具有更高速率、更低时延、更大容量、更安全可靠等特点。随着5G-A商用步伐加快，5G-A正成为赋能实体经济的新引擎。

在工业领域，5G-A的超高可靠性、超低时延等特性，可以满足工业生产对网络性能的更高要求。例如，在中兴通讯滨江工厂，业界首条全5G-A柔性生产线已经落地，实现了故障维修周期降低30%、生产效率提升10%以上。

在交通领域，5G-A可以支持车联网、自动驾驶等应用，推动交通运输体系更加智能化、高效化。例如，在中国移动雄安示范区，5G-A自动驾驶测试已经取得成功，为自动驾驶商用化奠定了基础。

5G未来发展空间广阔

展望未来，5G的发展空间仍然十分广阔。工业和信息化部总工程师赵志国表示，下一步将重点推进以下几项工作：

• 加快5G网络建设，推进5G-A商用步伐。
• 深化5G融合应用，推动5G赋能各行各业。
• 加强5G技术研发，提升5G产业链水平。
• 加强5G国际合作，共建共享5G美好未来。

5G的蓬勃发展，必将为经济社会高质量发展注入更加强劲的动力，为人民群众生活带来更加美好的未来。